Web3
DataMEDS AI (MEDS) Stock Rockets 87% on Helomics Cancer Lab Deal
CoinCentral·September 16, 2026·1 min read
DataMEDS AI (MEDS) closed up 87.20% at $1.62 after completing its $1.5 million acquisition of Helomics Corp. from Axe Compute (AGPU). The deal, structured through common stock and an acquisition note with no third-party debt, includes Helomics' CLIA/CAP-certified lab and Predictive Oncology CRO business.
Read at CoinCentralDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.